| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416788A1 Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2415826A1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 02/06/2002 | EP1178103A1 Purifying crude pufa oils |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1178048A1 Azabicycloalkane derivatives for use as serotonin reuptake inhibitors and 5HT2a antagonists |
| 02/06/2002 | EP1178047A1 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 02/06/2002 | EP1177794A2 Composition, containing lactobacillus bulgaricus and streptococcus thermophilus, for the treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases, and obesity |
| 02/06/2002 | EP1177789A2 Use of phytanic acid for the treatment of diabetes |
| 02/06/2002 | EP1177729A2 Pharmaceutical and food compositions containing "wood alcohols" or "wood sterols" useful for lowering serum cholesterol |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177217A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 02/06/2002 | EP1177200A1 Ligands for metabotropic glutamate receptors |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP1052987B1 Tablets to be crunched or sucked, comprising iron as active principle |
| 02/06/2002 | EP0971917B1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 02/06/2002 | EP0900077B1 Use of a toremifene metabolite for lowering serum cholesterol level. |
| 02/06/2002 | EP0790824B1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 02/06/2002 | EP0771198B1 Dihydro-2,3-benzodiazepine derivatives |
| 02/06/2002 | EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 02/06/2002 | EP0712936B1 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 02/06/2002 | EP0679081B1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/06/2002 | CN1334830A Hydrophilic ampholytic polymer |
| 02/06/2002 | CN1334821A Humanized antibodies to gamma-interferon |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/06/2002 | CN1334804A Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/06/2002 | CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2002 | CN1334742A Method of using lanreotide as somatostatin analogue |
| 02/06/2002 | CN1334740A Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |
| 02/06/2002 | CN1334736A Modulation of immune response by ribavirin |
| 02/06/2002 | CN1334116A Soft vinegar capsule |
| 02/06/2002 | CN1334104A Hypolipemic pill |
| 02/06/2002 | CN1334096A Fructo-iodine and its preparing process |
| 02/06/2002 | CN1334088A Process for preparing multi-vitamine bone peptide extract |
| 02/06/2002 | CN1078814C Pill for treating diabetes mellitus |
| 02/05/2002 | US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis |
| 02/05/2002 | US6344481 Thyromimetic antiobesity agents |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344474 Use of central cannabinoid receptor antagonists for regulating appetence |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344448 Composition for the treatment of hair loss |
| 02/05/2002 | US6344444 Arginine-silicate-inositol complex and use thereof |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
| 02/05/2002 | US6344437 Medicine drink food and feed having an action of strengthening bone |
| 02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
| 02/05/2002 | CA2019749C [.alpha.-(tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008222A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 01/31/2002 | WO2002008219A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008212A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics |
| 01/31/2002 | WO2002008210A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 01/31/2002 | WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 01/31/2002 | WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 01/31/2002 | WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002008188A1 N-substituted indoles useful in the treatment of diabetes |
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | WO2002008182A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 01/31/2002 | WO2002008179A1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2002007821A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007765A2 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
| 01/31/2002 | WO2002007754A2 New use |
| 01/31/2002 | WO2002007725A1 Method for treating fibrotic diseases or other indications ic |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2002007673A2 Calcilytic compounds |